Nigeria: Kano - Over 8,000 Patients Placed On TB Treatment in One Week

14 August 2023

Kano State Government has said a total of 8,277 patients were placed on Tuberculosis (TB) treatment in the last one week.

The government said this is the highest quarterly TB notification ever in Nigeria.

Commissioner of health, Dr Abubakar Labaran Yusuf, made this known while briefing journalists at the commemoration of the 2023 National TB Testing Week, on Monday.

He said, "Kano State being the most populous state in Nigeria and one of the five high TB burden states, the TB burden stood at 34,547 which represents expected notification of 8,637 TB patients per quarter and I am happy to inform you that just last week we placed a total of 8,277 TB patients which represents 96% of the total burden have been placed on TB treatment which is the highest quarterly TB notification ever in Nigeria.

"Nigeria is ranked 1st in Africa and 6th in the world among the 30 high TB-burdened countries. The 2022 National TB incident stood at 467,000 while a total of 218,000 (47%) people were notified and placed on TB treatment, with 249,000 (53%) undetected TB cases.

"According to the 2022 Global TB report over 72,000,000 lives were saved between 2000 and 2021 through joint efforts to End TB worldwide. Also, from the report the number of people worldwide that fell ill due to TB was 10.6 million, with 1.6 million deaths including 218,000 people living with HIV/AIDS worldwide."

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.